Intervention

Tryptophan

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown2

Clinical trials

3 shown

The Effects of Kynurenine Aminotransferase Inhibition in People With SchizophreniaNCT04013555 · 2020-01-20

Tryptophan MRI in People With Schizophrenia and Healthy ControlsNCT02067975 · 2014-08-14

Double Blind Study of Trp01 in Patients With Alzheimer's DiseaseNCT00202124 · 2001-04-01

Common conditions

Schizophrenia2 Alzheimer's Disease1 Schizoaffective Disorder1 Schizophreniform Disorder1

Leading sponsors

University of Maryland, Baltimore2 Queen's University1

Trial status mix

COMPLETED3

Phase mix

PHASE22

PHASE11

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.